Werken bij Siemens HealthineersPersInvestor Relations
  1. Home
  2. Medische beeldvorming
  3. Molecular Imaging
  4. MI World Summit 2026
  5. Advancing theranostics
MI Word Summit 2026 - Advancing theranostics

Advancing theranostics

The MI World Summit 2026 provides perspectives on radiopharmaceutical development, theranostic delivery models, regional access considerations, and approaches to implementing theranostics across different healthcare settings. Sessions explore operational, clinical, and infrastructure topics shaping theranostics programs around the world.

MI World Summit Audiocast

Advancing theranostics audiocast 

Coming soon

MI World Summit Article

Advancing theranostics article

Coming soon

Featured recordings

 

Future-proofing theranostics: Lessons learned building a molecular imaging center of excellence

Ryan Avery, MD

Theranostics delivery: Academic tier 1

Philipp Backhaus, MD

Theranostics delivery: Closing the gap—Meaningful access 
via outpatient theranostics

Munir Ghesani, MD, FACNM, FACR, FSNMMI

Radiohalogen theranostics: 
Unlocking its true potential with NextGenClick

Matthias Herth, PhD

Theranostics at an inflection point: Understanding treatment mechanisms as we enter the next era of precision radiopharmaceutical therapy

Thomas A. Hope, MD

Nuclear medicine in PUMCH: Clinical translation research and applications

Li Huo, MD

Theranostics delivery:​ An ICON and Australasian perspective

Nat Lenzo, MD, MS (Oncol), MBA

Unleashing the power of alpha radioligand therapy (ART)

Emanuele Ostuni, PhD

Computational nuclear oncology, theranostic digital twins, and predictive dosimetry towards precision radiopharmaceutical therapies

Arman Rahmim, PhD, DABSNM, FSNMMI

Advancing theranostics— Innovations needed for a sustained transformation of nuclear medicine

Michael Schäfers, MD

Scaling theranostics for 
greater patient access

Ishita B. Sen, MD

Panel discussions

 

Radiopharmaceuticals: Defining the future of therapy panel 

Panel discussion about radiopharmaceuticals defining the future of therapy. Panelists included Carl von Gall, MD; Matthias Herth, PhD; Thomas A. Hope, PhD; Emanuele Ostuni, PhD; Arman Rahmim, PhD, DABSNM, FSNMMI; and Michael Schäfers, MD.

Theranostics delivery models panel

Panel discussion about theranostics delivery models. Panelists included Réne Fernández, MD; Phillip Backhaus, MD; Munir Ghesani, MD, FACNM, FACR, FSNMMI; and Nat Lenzo, MD.

Explore other MI World Summit sessions